Anagenics Limited Reports Q3 Financial Growth

Anagenics Limited (AU:AN1) has released an update.

Anagenics Limited has reported a 13% year-on-year increase in Q3 customer cash receipts to $2.7M, despite overall cash payments also rising to $3.5M. The company is undergoing cost-saving measures, including fee pauses for Non-Executive Directors and a reduction in staff numbers from 37 to 20, under the leadership of CEO Karen Matthews. Anagenics has also completed a share placement raising $1.3M net and continues to explore mergers and acquisitions cautiously amid the current economic climate.

For further insights into AU:AN1 stock, check out TipRanks’ Stock Analysis page.